OBJECTIVE: The present study investigated a new set of families of Latin American ancestry in order to detect the location of genes predisposing to schizophrenia and related psychotic disorders. METHOD: A genome-wide scan was performed for 175 newly recruited families with at least two siblings suffering from a psychotic disorder. Best-estimate consensus procedures were used to arrive at diagnoses, and nonparametric allele-sharing statistics were calculated to detect linkage. RESULTS: Genome-wide significant evidence for linkage for the phenotype of DSM-IV schizophrenia or schizoaffective disorder was found in a region on chromosome 17q21 (lod score, 3.33). A region on chromosome 15q22-23 showed suggestive evidence of linkage with this same phenotype (lod score, 2.11). Analyses using a broader model (any psychosis) yielded evidence of suggestive linkage for the 17q21 region only, and no region achieved genome-wide significance of linkage. CONCLUSIONS: The new set of 175 families of Mexican and Central American ancestry delineates two new loci likely to harbor predisposition genes for schizophrenia and schizoaffective disorder. The region with the strongest support for linkage in this sample, 17q21, has been implicated in meta-analyses of schizophrenia genome screens, but the authors found no previous reports of it as a locus for schizophrenia in specific population- or family-based studies, and it may represent the location of a schizophrenia predisposition gene (or genes) of special relevance in Mexican and Central American populations.
OBJECTIVE: The present study investigated a new set of families of Latin American ancestry in order to detect the location of genes predisposing to schizophrenia and related psychotic disorders. METHOD: A genome-wide scan was performed for 175 newly recruited families with at least two siblings suffering from a psychotic disorder. Best-estimate consensus procedures were used to arrive at diagnoses, and nonparametric allele-sharing statistics were calculated to detect linkage. RESULTS: Genome-wide significant evidence for linkage for the phenotype of DSM-IV schizophrenia or schizoaffective disorder was found in a region on chromosome 17q21 (lod score, 3.33). A region on chromosome 15q22-23 showed suggestive evidence of linkage with this same phenotype (lod score, 2.11). Analyses using a broader model (any psychosis) yielded evidence of suggestive linkage for the 17q21 region only, and no region achieved genome-wide significance of linkage. CONCLUSIONS: The new set of 175 families of Mexican and Central American ancestry delineates two new loci likely to harbor predisposition genes for schizophrenia and schizoaffective disorder. The region with the strongest support for linkage in this sample, 17q21, has been implicated in meta-analyses of schizophrenia genome screens, but the authors found no previous reports of it as a locus for schizophrenia in specific population- or family-based studies, and it may represent the location of a schizophrenia predisposition gene (or genes) of special relevance in Mexican and Central American populations.
Authors: Veronica J Vieland; Kimberly A Walters; Thomas Lehner; Marco Azaro; Kathleen Tobin; Yungui Huang; Linda M Brzustowicz Journal: Am J Psychiatry Date: 2014-03 Impact factor: 18.112
Authors: Hans-Gert Bernstein; Karl-Heinz Smalla; Diana Dürrschmidt; Gerburg Keilhoff; Henrik Dobrowolny; Johann Steiner; Andrea Schmitt; Michael R Kreutz; Bernhard Bogerts Journal: Neuromolecular Med Date: 2012-06-19 Impact factor: 3.843
Authors: Parastoo Momeni; Karen DeTucci; Richard E Straub; Daniel R Weinberger; Peter Davies; Jordan Grafman; John Hardy; Edward D Huey Journal: Neurocase Date: 2010-01-18 Impact factor: 0.881
Authors: Veronica J Vieland; Kimberly A Walters; Marco Azaro; Linda M Brzustowicz; Thomas Lehner Journal: Hum Hered Date: 2014-06-21 Impact factor: 0.444
Authors: Ke-Sheng Wang; Xuefeng Liu; Tania Bedard Arana; Nicholas Thompson; Henry Weisman; Cecilia Devargas; Chunxiang Mao; Brenda Bin Su; Cynthia Camarillo; Michael A Escamilla; Chun Xu Journal: J Mol Neurosci Date: 2013-07-17 Impact factor: 3.444
Authors: Peter Kochunov; David C Glahn; Thomas E Nichols; Anderson M Winkler; Elliot L Hong; Henry H Holcomb; Jason L Stein; Paul M Thompson; Joanne E Curran; Melanie A Carless; Rene L Olvera; Matthew P Johnson; Shelley A Cole; Valeria Kochunov; Jack Kent; John Blangero Journal: Front Neurosci Date: 2011-10-19 Impact factor: 4.677
Authors: Y Okahisa; M Kodama; M Takaki; T Inada; N Uchimura; M Yamada; N Iwata; M Iyo; I Sora; N Ozaki; H Ujike Journal: Curr Neuropharmacol Date: 2011-03 Impact factor: 7.363
Authors: Daniela Galimberti; Bernardo Dell'Osso; Chiara Fenoglio; Chiara Villa; Francesca Cortini; Maria Serpente; Sarah Kittel-Schneider; Johannes Weigl; Maria Neuner; Juliane Volkert; C Leonhard; David G Olmes; Juliane Kopf; Claudia Cantoni; Elisa Ridolfi; Carlotta Palazzo; Laura Ghezzi; Nereo Bresolin; A C Altamura; Elio Scarpini; Andreas Reif Journal: PLoS One Date: 2012-04-10 Impact factor: 3.240